Herzlich Wifikommen to Munich and the Twelfth European International Kidney Cancer Symposium! On behalf of the Board of Directors, the Medical and Scientific Steering Committee, and the staff of the Kidney Cancer Association, we welcome you to Munich, Germany.

We are delighted to have you with us and hope you will fmd the Symposium productive and informative. This special event would not have been possible without the dedication and hard work of the Symposium Planning Committee — Laurence Albiges, M.D., Ph.D., Axel Bex, M.D., Ph.D., Viktor Grunwald, M.D., Sylvie Negrier, M.D., Ph.D., Camillo Porta, M.D., and Grant D. Stewart, M.D., Ph.D. They have created the scientific program which we are confident will inspire you to continue your work in kidney cancer.

Since 1990, the Kidney Cancer Association has dedicated itself to the eradication of kidney cancer, improving care and increasing survival of kidney cancer patients worldwide. This is the only organization of its kind dedicated to serving kidney cancer patients, their families, and physicians around the world. As we work to globalize our organization, we look forward to continuing our collaboration with you so that we may be of further assistance to you and your patients.

Please note that as part of our commitment to environmental responsibility, Symposium presentations will be provided online this year.

Thank you again for joining us for the Twelfth European International Kidney Cancer Symposium. If there is anything with which we can help you during the next two days, please do not hesitate to call on us.

Christopher G. Wood, M.D.,
FACS
Chair, Board of Directors
Kidney Cancer Association

Carolyn Konosky
Co-CEO
Kidney Cancer Association